Connect with us

Cannabis

Cannabis Europa Goes Global: North American Expansion, Fall 2019

Published

on

Reading Time: 2 minutes

 

  • Demand from Canadian and American cannabis firms has prompted UK-based Cannabis Europa to take their brand across the Atlantic
  • The public can vote on their preferred city to host the next conference with the locations to be announced soon
  • The recent Cannabis Europa London was well received, with over 1200 guests in attendance from all across the world.

As the giants of the American and Canadian cannabis industries eye the lucrative emerging European cannabis market, the founders of Cannabis Europa are bringing the continent’s premier cannabis networking event to North America.

Although the European market has seen a year of rapid change, with the UK, Luxembourg and France moving down the path to legalization; legalization is complex and varies greatly from country to country. Helping North Americans understand this complex web will be the central theme of Cannabis Europa across the Atlantic.

Europe’s medical cannabis industry alone is estimated to be worth almost $70 billion by 2028[1] and has already attracted significant investment from North American firms. This number is eclipsed by any future legal recreational market, representing an estimated value of $155 billion by 2028.

Alastair Moore, Managing Director and co-founder of Cannabis Europa explained the reason behind taking their highly successful conference out of Europe for the first time: “Europe is the logical next step for North American cannabis companies looking to expand, and the feedback that we got from these companies who attended our events inLondon and Paris was that there is a large demand for information about the market closer to home. In essence, Americans and Canadians want the opportunity to meet Europe’s gatekeepers and tastemakers and the chance to understand the intricacies of this hugely complex yet lucrative market.

The public is urged to vote for their favourite location on the Cannabis Europa Website.

Cannabis Europa London – the flagship event of the first ever European Cannabis Week, which took place on the 24th and 25th of June – has been hailed as a success, with over 1200 guests and over 80 journalists in attendance from all over the world. European Cannabis Week saw over 2500 people attend events across the UK’s capital.

Further information will be announced soon. Check the website and social media for updates.

Cannabis

Digipath CEO Todd Denkin Interviewed by CEO Roadshow

Published

on

Reading Time: 1 minute

 

Digipath, Inc. (OTCQB: DIGP) (“DIGP” or the “Company”), a service-oriented independent testing laboratory, data analytics and formulation firm focused on the developing cannabis and hemp markets, is pleased to announce that Company CEO Todd Denkin was recently interviewed by CEO Roadshow with veteran journalist Mike Elliott.

In this interview, Denkin discusses the Company’s recent provisional patent applications involving terpene technology. He also discusses Digipath’s newest business unit, GroSciences and the molecular assay it has developed to distinguish hemp from drug-type cannabis, and the status of the Company’s expansion into Colombia.

“It’s always a pleasure to sit down with Mr. Elliott, who is a true professional with a significant following,” stated Todd Denkin, CEO, Digipath Inc. “In this interview we covered some of the more exciting things happening for Digipath and its shareholders. “Please take a moment to listen to the interview at http://ceoroadshow.com/digipath-interview/,” added Denkin.

 

SOURCE Digipath, Inc.

 

 

Continue Reading

Cannabis

Vireo Health Launches New York’s First Same-Day Marijuana Delivery Service

Published

on

Reading Time: 1 minute

 

Vireo Health of New York (“Vireo” or the “Company”), a subsidiary of Vireo Health International (CSE: VREO), a leading physician-led, science-focused multi-state cannabis company, today announced that patients living in the New York City metro area, Westchester County, and Nassau County now have access to free, same-day marijuana delivery.

Launched in April 2017, Vireo’s medical marijuana home delivery service has rapidly expanded. Since its inception, the Company has made more than 25,000 home deliveries to patients. With over 1,000 Google reviews with an average 4.9 out of 5 star rating, it is now the first company in New York to offer a free same-day delivery option.

“Our same-day home delivery service is designed to match the convenience that New Yorkers have become accustomed to in the era of Amazon, Uber and Seamless,” said Founder and Chief Executive Officer, Kyle Kingsley, M.D.  “The growing popularity of our home delivery service has allowed us to achieve the economies of scale necessary to offer same-day delivery throughout the Greater New York City area.”

Vireo’s home delivery service was designed by a team of security experts, pharmacists, and health-care providers. “As a physician-led company, our goal is to provide safe and effective products in a trusted and supportive environment, and nothing is safer than one’s own home. We want to ensure that all our patients do not feel stigmatized and can receive the highest quality service and products with the convenience they deserve,” said Stephen Dahmer, M.D., Chief Medical Officer of Vireo Health.

Patients who place orders by 12:00 p.m. EDT will be eligible to receive free same-day delivery. Payment for deliveries can be made using CanPay, a cannabis debit payment app available on iPhone and Android devices. More information is available online at www.vireohealth.com/ny/delivery.

 

SOURCE Vireo Health International, Inc.

Continue Reading

Cannabis

Choom Announces Warrant Extension

Published

on

Reading Time: 2 minutes

 

Vancouver-based cannabis brand Choom™ (CSE: CHOO; OTCQB: CHOOF) has amended the expiry date of 2,352,500 outstanding share purchase warrants that were issued pursuant to a private placement completed in February 2018 (the “2018 Warrants”). Each 2018 Warrant currently entitles the holder to purchase one common share (a “Common Share”) in the capital of the Company at a price of $0.75 per Common Share at any time prior to 5:00 p.m. (Vancouver Time) on August 6, 2019 (the “2018 Warrant Expiry Date”). Subject to Canadian Securities Exchange approval, the 2018 Warrant Expiry Date will be extended to August 6, 2020. All other terms of the 2018 Warrants will remain the same.

Say hello to Choom™
Choom™ is an emerging adult use cannabis company whose mission is to establish one of the largest retail networks in Canada. The Choom brand is inspired by Hawaii’s “Choom Gang”—a group of buddies in Honolulu during the 1970’s who loved to smoke weed—or as the locals called it, “Choom”. Evoking the spirit of the original Choom Gang, our brand caters to the Canadian adult use market with the ethos of ‘cultivating good times’. Choom™ is focused on delivering an elevated customer experience through our curated retail environments, offering a diversity of brands for Canadians across a national retail network.

“Chris Bogart” 
President & CEO

Cautionary Statement:

NEITHER THE CANADIAN SECURITIES EXCHANGE NOR ITS REGULATIONS SERVICES PROVIDER HAVE REVIEWED OR ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.

Forward-looking information           
This news release contains forward-looking information relating to the Company’s proposed activities and other statements that are not historical facts. Forward-looking information relates to management’s future outlook and anticipated events or results and include statements or information regarding the future plans or prospects of the Company. Although management of the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. These factors include risks and uncertainties associated with or arising as a result of delays in obtaining or an inability to obtain required regulatory approvals, access to sufficient quantities of cannabis, the results of diligence investigations, the actions of third parties, the results of negotiations with third parties, developments in the cannabis sector, the ability to access sufficient capital from internal and external sources, reliance on key personnel, regulatory risks and delays and other risks and uncertainties discussed in the management discussion and analysis section of the Company’s interim and most recent annual financial statement or other reports and filings, including those made with the CSE and applicable Canadian securities regulators. There can be no assurance that such forward looking information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward looking information.

SOURCE Choom Holdings Inc.

Continue Reading

Trending Online

Grassnews is a news publishing website which digests / hand picks the latest news about the cannabis industry, and serves them to you daily.

Contact us: pressroom@grassnews.net

© Grassnews.net 2019 - part of PICANTE Media. All rights reserved. Registered in Romania under Proshirt SRL, Company number: 2134306, EU VAT ID: RO21343605. Office address: Blvd. 1 Decembrie 1918 nr.5, Targu Mures, Romania